secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alector, Inc. (ALEC)
CIK:        0001653087
Form:       8-K
Filed at:   2022-03-29T23:59:59+00:00
Accession:  0000950170-22-004925
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alector appoints Gary Romano, M.D., Ph.D., as CMO effective May 23, 2022
------------------------------------------------------------------------

- Appointed Gary Romano, M.D., Ph.D., as Chief Medical Officer, effective May 23, 2022.
- Annual base salary of $475,000; eligible for performance bonus of 40%; equity awards: $3.9M stock option (4-yr vest) and $975K RSU (3-yr vest).
- He brings over 25 years of neurodegenerative disease experience, previously CMO at Passage Bio and roles at Janssen and Merck.
- Interim CMO Sam Jackson, M.D., M.B.A., is leaving Alector to pursue a new opportunity; will continue as a consultant.
- He will report to President and Head of R&D Sara Kenkare-Mitra.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653087/000095017022004925/0000950170-22-004925-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653087/000095017022004925/alec-20220329.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-004925

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer